Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature. (Record no. 27423682)

MARC details
000 -LEADER
fixed length control field 02586 a2200685 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517165241.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201807s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1557-3265
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1158/1078-0432.CCR-17-1423
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Craddock, Charles F
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20180723
245 00 - TITLE STATEMENT
Title Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical cancer research : an official journal of the American Association for Cancer Research
Date of publication, distribution, etc. Nov 2017
300 ## - PHYSICAL DESCRIPTION
Extent 6430-6440 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Azacitidine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Combined Modality Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclin-Dependent Kinase Inhibitor p16
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclin-Dependent Kinase Inhibitor p18
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Histone Deacetylase Inhibitors
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hydroxamic Acids
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Isocitrate Dehydrogenase
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukemia, Myeloid, Acute
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mutation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Suppressor Protein p53
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vorinostat
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Houlton, Aimee E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Quek, Lynn Swun
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ferguson, Paul
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gbandi, Emma
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Roberts, Corran
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Metzner, Marlen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Garcia-Martin, Natalia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kennedy, Alison
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hamblin, Angela
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Raghavan, Manoj
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nagra, Sandeep
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dudley, Louise
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wheatley, Keith
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name McMullin, Mary Frances
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pillai, Srinivas P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kelly, Richard J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Siddique, Shamyla
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dennis, Michael
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cavenagh, Jamie D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vyas, Paresh
773 0# - HOST ITEM ENTRY
Title Clinical cancer research : an official journal of the American Association for Cancer Research
Related parts vol. 23
-- no. 21
-- p. 6430-6440
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1158/1078-0432.CCR-17-1423">https://doi.org/10.1158/1078-0432.CCR-17-1423</a>
Public note Available from publisher's website

No items available.